Neuroendocrine Tumor Treatment Global Market Report 2025

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,490	200 Pages	The Business Research Company	February, 2025	BRC19655109

Best Price Guarantee
Price	from $4,490
Length	200 Pages
Publisher	The Business Research Company
Published Date	February, 2025
SKU	BRC19655109

Neuroendocrine Tumor Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on neuroendocrine tumor treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Description:

Where is the largest and fastest growing market for neuroendocrine tumor treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The neuroendocrine tumor treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Product: Somatostatin Analogs (SSAs); Targeted Therapy; Chemotherapy; Others Products

2) By Indication: Lungs; Pancreas; Gastrointestinal; Others Indications

3) By End-Users: Hospitals; Oncology Centers; Other End-Users

Subsegments:

1) By Somatostatin Analogs (SSAs): Octreotide; Lanreotide

2) By Targeted Therapy: Tyrosine Kinase Inhibitors (TKIs); Peptide Receptor Radionuclide Therapy (PRRT)

3) By Chemotherapy: Traditional Chemotherapy Agents; Combination Chemotherapy Regimens

4) By Other Products: Immunotherapy; Supportive Care Medications

Companies Mentioned: Pfizer Inc.; F Hoffmann-La Roche AG; Abbvie Inc.; Novartis AG; Sanofi SA

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.

1. Executive Summary
2. Neuroendocrine Tumor Treatment Market Characteristics
3. Neuroendocrine Tumor Treatment Market Trends And Strategies
4. Neuroendocrine Tumor Treatment Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market
5. Global Neuroendocrine Tumor Treatment Growth Analysis And Strategic Analysis Framework: 5.1. Global Neuroendocrine Tumor Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints); 5.2. Analysis Of End Use Industries; 5.3. Global Neuroendocrine Tumor Treatment Market Growth Rate Analysis; 5.4. Global Neuroendocrine Tumor Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion); 5.5. Global Neuroendocrine Tumor Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion); 5.6. Global Neuroendocrine Tumor Treatment Total Addressable Market (TAM)
6. Neuroendocrine Tumor Treatment Market Segmentation: 6.1. Global Neuroendocrine Tumor Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Somatostatin Analogs (SSAs); Targeted Therapy; Chemotherapy; Others Products; 6.2. Global Neuroendocrine Tumor Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Lungs; Pancreas; Gastrointestinal; Others Indications; 6.3. Global Neuroendocrine Tumor Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Hospitals; Oncology Centers; Other End-Users; 6.4. Global Neuroendocrine Tumor Treatment Market, Sub-Segmentation Of Somatostatin Analogs (SSAs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Octreotide; Lanreotide; 6.5. Global Neuroendocrine Tumor Treatment Market, Sub-Segmentation Of Targeted Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Tyrosine Kinase Inhibitors (TKIs); Peptide Receptor Radionuclide Therapy (PRRT); 6.6. Global Neuroendocrine Tumor Treatment Market, Sub-Segmentation Of Chemotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Traditional Chemotherapy Agents; Combination Chemotherapy Regimens; 6.7. Global Neuroendocrine Tumor Treatment Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Immunotherapy; Supportive Care Medications
7. Neuroendocrine Tumor Treatment Market Regional And Country Analysis: 7.1. Global Neuroendocrine Tumor Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 7.2. Global Neuroendocrine Tumor Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Neuroendocrine Tumor Treatment Market: 8.1. Asia-Pacific Neuroendocrine Tumor Treatment Market Overview; Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies; 8.2. Asia-Pacific Neuroendocrine Tumor Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 8.3. Asia-Pacific Neuroendocrine Tumor Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 8.4. Asia-Pacific Neuroendocrine Tumor Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Neuroendocrine Tumor Treatment Market: 9.1. China Neuroendocrine Tumor Treatment Market Overview; 9.2. China Neuroendocrine Tumor Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion; 9.3. China Neuroendocrine Tumor Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion; 9.4. China Neuroendocrine Tumor Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Neuroendocrine Tumor Treatment Market: 10.1. India Neuroendocrine Tumor Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 10.2. India Neuroendocrine Tumor Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 10.3. India Neuroendocrine Tumor Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Neuroendocrine Tumor Treatment Market: 11.1. Japan Neuroendocrine Tumor Treatment Market Overview; 11.2. Japan Neuroendocrine Tumor Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 11.3. Japan Neuroendocrine Tumor Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 11.4. Japan Neuroendocrine Tumor Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Neuroendocrine Tumor Treatment Market: 12.1. Australia Neuroendocrine Tumor Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 12.2. Australia Neuroendocrine Tumor Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 12.3. Australia Neuroendocrine Tumor Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Neuroendocrine Tumor Treatment Market: 13.1. Indonesia Neuroendocrine Tumor Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 13.2. Indonesia Neuroendocrine Tumor Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 13.3. Indonesia Neuroendocrine Tumor Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Neuroendocrine Tumor Treatment Market: 14.1. South Korea Neuroendocrine Tumor Treatment Market Overview; 14.2. South Korea Neuroendocrine Tumor Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 14.3. South Korea Neuroendocrine Tumor Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 14.4. South Korea Neuroendocrine Tumor Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Neuroendocrine Tumor Treatment Market: 15.1. Western Europe Neuroendocrine Tumor Treatment Market Overview; 15.2. Western Europe Neuroendocrine Tumor Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 15.3. Western Europe Neuroendocrine Tumor Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 15.4. Western Europe Neuroendocrine Tumor Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Neuroendocrine Tumor Treatment Market: 16.1. UK Neuroendocrine Tumor Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 16.2. UK Neuroendocrine Tumor Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 16.3. UK Neuroendocrine Tumor Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Neuroendocrine Tumor Treatment Market: 17.1. Germany Neuroendocrine Tumor Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 17.2. Germany Neuroendocrine Tumor Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 17.3. Germany Neuroendocrine Tumor Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Neuroendocrine Tumor Treatment Market: 18.1. France Neuroendocrine Tumor Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 18.2. France Neuroendocrine Tumor Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 18.3. France Neuroendocrine Tumor Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Neuroendocrine Tumor Treatment Market: 19.1. Italy Neuroendocrine Tumor Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 19.2. Italy Neuroendocrine Tumor Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 19.3. Italy Neuroendocrine Tumor Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Neuroendocrine Tumor Treatment Market: 20.1. Spain Neuroendocrine Tumor Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 20.2. Spain Neuroendocrine Tumor Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 20.3. Spain Neuroendocrine Tumor Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Neuroendocrine Tumor Treatment Market: 21.1. Eastern Europe Neuroendocrine Tumor Treatment Market Overview; 21.2. Eastern Europe Neuroendocrine Tumor Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 21.3. Eastern Europe Neuroendocrine Tumor Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 21.4. Eastern Europe Neuroendocrine Tumor Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Neuroendocrine Tumor Treatment Market: 22.1. Russia Neuroendocrine Tumor Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 22.2. Russia Neuroendocrine Tumor Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 22.3. Russia Neuroendocrine Tumor Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Neuroendocrine Tumor Treatment Market: 23.1. North America Neuroendocrine Tumor Treatment Market Overview; 23.2. North America Neuroendocrine Tumor Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 23.3. North America Neuroendocrine Tumor Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 23.4. North America Neuroendocrine Tumor Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Neuroendocrine Tumor Treatment Market: 24.1. USA Neuroendocrine Tumor Treatment Market Overview; 24.2. USA Neuroendocrine Tumor Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 24.3. USA Neuroendocrine Tumor Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 24.4. USA Neuroendocrine Tumor Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Neuroendocrine Tumor Treatment Market: 25.1. Canada Neuroendocrine Tumor Treatment Market Overview; 25.2. Canada Neuroendocrine Tumor Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 25.3. Canada Neuroendocrine Tumor Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 25.4. Canada Neuroendocrine Tumor Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Neuroendocrine Tumor Treatment Market: 26.1. South America Neuroendocrine Tumor Treatment Market Overview; 26.2. South America Neuroendocrine Tumor Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 26.3. South America Neuroendocrine Tumor Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 26.4. South America Neuroendocrine Tumor Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Neuroendocrine Tumor Treatment Market: 27.1. Brazil Neuroendocrine Tumor Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 27.2. Brazil Neuroendocrine Tumor Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 27.3. Brazil Neuroendocrine Tumor Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Neuroendocrine Tumor Treatment Market: 28.1. Middle East Neuroendocrine Tumor Treatment Market Overview; 28.2. Middle East Neuroendocrine Tumor Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 28.3. Middle East Neuroendocrine Tumor Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 28.4. Middle East Neuroendocrine Tumor Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Neuroendocrine Tumor Treatment Market: 29.1. Africa Neuroendocrine Tumor Treatment Market Overview; 29.2. Africa Neuroendocrine Tumor Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 29.3. Africa Neuroendocrine Tumor Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 29.4. Africa Neuroendocrine Tumor Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Neuroendocrine Tumor Treatment Market Competitive Landscape And Company Profiles: 30.1. Neuroendocrine Tumor Treatment Market Competitive Landscape; 30.2. Neuroendocrine Tumor Treatment Market Company Profiles; 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis; 30.2.2. F Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis; 30.2.3. Abbvie Inc. Overview, Products and Services, Strategy and Financial Analysis; 30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis; 30.2.5. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
31. Neuroendocrine Tumor Treatment Market Other Major And Innovative Companies: 31.1. Bristol-Myers Squibb Company; 31.2. AstraZeneca; 31.3. Takeda Pharmaceutical; 31.4. Eli Lilly And Company; 31.5. Amgen Inc.; 31.6. Merck & Co. Inc.; 31.7. Boehringer Ingelheim International GmbH; 31.8. Servier; 31.9. Teva Pharmaceutical Industries Ltd.; 31.10. Ipsen Pharma SAS; 31.11. Exelixis Inc.; 31.12. Advanced Accelerator Applications SA; 31.13. Hutchison Medipharma Ltd.; 31.14. Tarveda Therapeutics; 31.15. GlycoMira Therapeutics Inc.
32. Global Neuroendocrine Tumor Treatment Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Neuroendocrine Tumor Treatment Market
34. Recent Developments In The Neuroendocrine Tumor Treatment Market
35. Neuroendocrine Tumor Treatment Market High Potential Countries, Segments and Strategies: 35.1 Neuroendocrine Tumor Treatment Market In 2029 - Countries Offering Most New Opportunities; 35.2 Neuroendocrine Tumor Treatment Market In 2029 - Segments Offering Most New Opportunities; 35.3 Neuroendocrine Tumor Treatment Market In 2029 - Growth Strategies; 35.3.1 Market Trend Based Strategies; 35.3.2 Competitor Strategies
36. Appendix: 36.1. Abbreviations; 36.2. Currencies; 36.3. Historic And Forecast Inflation Rates; 36.4. Research Inquiries; 36.5. The Business Research Company; 36.6. Copyright And Disclaimer